Published in Eur J Neurol on September 01, 2011
Key issues in essential tremor genetics research: Where are we now and how can we move forward? Tremor Other Hyperkinet Mov (N Y) (2013) 0.87
Autosomal dominant essential tremor: a novel family with anticipation. Neurol Sci (2012) 0.78
Tracing European founder lineages in the Near Eastern mtDNA pool. Am J Hum Genet (2000) 7.06
Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet (1993) 6.53
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language. Am J Hum Genet (2000) 4.72
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology (2010) 4.06
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature (1994) 3.46
A signal, from human mtDNA, of postglacial recolonization in Europe. Am J Hum Genet (2001) 3.28
The geographic distribution of human Y chromosome variation. Genetics (1997) 3.18
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet (2000) 2.96
The Huntington's disease candidate region exhibits many different haplotypes. Nat Genet (1992) 2.84
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology (2007) 2.51
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet (1996) 2.40
A weighted and directed interareal connectivity matrix for macaque cerebral cortex. Cereb Cortex (2012) 2.35
Weight consistency specifies regularities of macaque cortical networks. Cereb Cortex (2010) 2.30
Population structure in the Mediterranean basin: a Y chromosome perspective. Ann Hum Genet (2006) 2.28
Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol (2013) 2.25
Epidemiology of nephrolithiasis. J Nephrol (2000) 2.22
Y chromosomal haplogroup J as a signature of the post-neolithic colonization of Europe. Hum Genet (2004) 2.21
Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am J Med Genet A (2003) 2.15
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. Neurology (2011) 2.10
Murine Otx1 and Drosophila otd genes share conserved genetic functions required in invertebrate and vertebrate brain development. Development (1998) 2.09
Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci Lett (2000) 1.98
Combined use of biallelic and microsatellite Y-chromosome polymorphisms to infer affinities among African populations. Am J Hum Genet (1999) 1.81
Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood (2000) 1.78
Idiopathic cerebellar ataxia associated with celiac disease: lack of distinctive neurological features. J Neurol Neurosurg Psychiatry (1999) 1.68
Epilepsy and brain abnormalities in mice lacking the Otx1 gene. Nat Genet (1996) 1.63
Menopause and cardiovascular disease: the evidence. Climacteric (2007) 1.60
Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's disease. Neurology (1993) 1.58
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. Eur J Neurol (2012) 1.57
Characteristics, associations and outcome of absent pulmonary valve syndrome in the fetus. Ultrasound Obstet Gynecol (2004) 1.54
Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci U S A (1999) 1.53
Orocecal transit time and bacterial overgrowth in patients with Crohn's disease. J Clin Gastroenterol (2000) 1.52
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. Eur J Neurol (2014) 1.50
Managing cardiovascular risk in menopausal women. Climacteric (2006) 1.47
Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders, Italian Society of Neurology. Ital J Neurol Sci (1997) 1.46
REM sleep behavior disorders in multiple system atrophy. Neurology (1997) 1.42
Complicated migraine studied by phosphorus magnetic resonance spectroscopy. Cephalalgia (1990) 1.41
Lower extremity counterpart of the Poland syndrome. Clin Genet (1999) 1.40
Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol (2001) 1.40
Sneddon syndrome presenting with hemicranic attacks: a case report. Acta Neurol Scand (1991) 1.39
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc Natl Acad Sci U S A (1996) 1.39
Gamete intrafallopian transfer: prospective randomized comparison between hysteroscopic and laparoscopic transfer techniques. Fertil Steril (1995) 1.39
A levodopa kinetic-dynamic study of the rate of progression in Parkinson's disease. Neurology (1998) 1.38
Cancer genetic counselling. Ann Oncol (2005) 1.38
Disequilibrium of multiple DNA markers on the human Y chromosome. Ann Hum Genet (1992) 1.37
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients. Eur J Neurol (2008) 1.37
RET mutations in exons 13 and 14 of FMTC patients. Oncogene (1995) 1.35
Unawareness of dyskinesias in Parkinson's and Huntington's diseases. Neurol Sci (2001) 1.32
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol (2000) 1.32
Evidence that cochlear-implanted deaf patients are better multisensory integrators. Proc Natl Acad Sci U S A (2007) 1.30
REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study. Neurol Sci (2005) 1.30
Involvement of the HLXB9 homeobox gene in Currarino syndrome. Am J Hum Genet (2000) 1.29
Protection against malaria morbidity: near-fixation of the alpha-thalassemia gene in a Nepalese population. Am J Hum Genet (1991) 1.28
Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res (1989) 1.26
The alpha-synuclein gene in multiple system atrophy. J Neurol Neurosurg Psychiatry (2006) 1.25
Reduced penetrance of the Huntington's disease mutation. Hum Mol Genet (1997) 1.25
HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc Natl Acad Sci U S A (1998) 1.22
The human Y chromosome shows a low level of DNA polymorphism. Ann Hum Genet (1990) 1.22
DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene (1994) 1.22
Network analyses of Y-chromosomal types in Europe, northern Africa, and western Asia reveal specific patterns of geographic distribution. Am J Hum Genet (1998) 1.21
Reversible and irreversible changes in nucleosome structure along the c-fos and c-myc oncogenes following inhibition of transcription. J Mol Biol (1990) 1.20
The RAI-PC: an assessment instrument for palliative care in all settings. Am J Hosp Palliat Care (2003) 1.18
Multisensory anatomical pathways. Hear Res (2009) 1.18
Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes. Diabet Med (2008) 1.17
Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis (2007) 1.16
Stiff-man syndrome associated with nocturnal myoclonus and epilepsy. J Neurol Neurosurg Psychiatry (1978) 1.16
Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial. Neurology (2011) 1.15
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology (2011) 1.15
Congenital infiltrating lipomatosis of the face: report of cases and review of the literature. J Oral Maxillofac Surg (1987) 1.15
Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci (2006) 1.15
The role of sensory cues in the rehabilitation of parkinsonian patients: a comparison of two physical therapy protocols. Mov Disord (2000) 1.14
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur J Immunol (1997) 1.14
Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington disease. Hum Mol Genet (1994) 1.13
Characterization of ligurian melanoma families and risk of occurrence of other neoplasia. Int J Cancer (1999) 1.13
MEFV mutations in Behçet's disease. Hum Mutat (2000) 1.13
Congenital constriction band of the upper arm: the role of three-dimensional ultrasound in diagnosis, counseling and multidisciplinary consultation. Ultrasound Obstet Gynecol (2004) 1.13
Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia I. Am J Hum Genet (1994) 1.13